{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:42:19Z","timestamp":1790048539316,"version":"4.0.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1093\/ije\/29.6.1076","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:50:44Z","timestamp":1027723844000},"page":"1076-1084","source":"Crossref","is-referenced-by-count":27,"title":["Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model"],"prefix":"10.1093","volume":"29","author":[{"given":"Hein","family":"Stigum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Magnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helvi Holm","family":"Samdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Nord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,12]]},"reference":[{"key":"key\n\t\t\t\t20170712061443_R1","doi-asserted-by":"crossref","unstructured":"Seroepidemiology of the human T-cell leukaemia\/lymphoma viruses in Europe. The HTLV European Research Network. J Acquir Immune Defic Syndr Hum Retrovirol1996;13:68\u201377.","DOI":"10.1097\/00042560-199609000-00010"},{"key":"key\n\t\t\t\t20170712061443_R2","doi-asserted-by":"crossref","unstructured":"de Th\u00e9 G, Kazanji M. An HTLV I\/II vaccine: from animal model to clinical trials? J Acquir Immune Defic Syndr Hum Retrovirol1996; 13(Suppl.1):15\u201319.","DOI":"10.1097\/00042560-199600001-00029"},{"key":"key\n\t\t\t\t20170712061443_R3","unstructured":"Centers for Disease Control. Recommendations for counseling persons infected with Human T-Lymphotrophic Virus, types I and II. MMWR1993;42:1\u201313."},{"key":"key\n\t\t\t\t20170712061443_R4","doi-asserted-by":"crossref","unstructured":"Hall WW, Ishak R, Zhu SW et al. Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection. J Acquir Immune Defic Syndr Hum Retrovirol1996; 13(Suppl.1):S204\u201314.","DOI":"10.1097\/00042560-199600001-00031"},{"key":"key\n\t\t\t\t20170712061443_R5","doi-asserted-by":"crossref","unstructured":"Kaplan JE, Khabbaz RF, Murphy EL et al. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol1996;12:193\u2013201.","DOI":"10.1097\/00042560-199606010-00014"},{"key":"key\n\t\t\t\t20170712061443_R6","doi-asserted-by":"crossref","unstructured":"Taylor GP. The epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Hum Retrovirol1996;13(Suppl.1):S8\u201314.","DOI":"10.1097\/00042560-199600001-00003"},{"key":"key\n\t\t\t\t20170712061443_R7","unstructured":"Samdal HH, Skaug K, Stigum H, Hervig T, Kjeldsen-Kragh J, Skar AG. HTLV examination of Norwegian blood donors. Tidsskr Nor Laegeforen1999;119:206\u201308."},{"key":"key\n\t\t\t\t20170712061443_R8","doi-asserted-by":"crossref","unstructured":"Tynell E, Andersson S, Lithander E et al. Screening for human T cell leukaemia\/lymphoma virus among blood donors in Sweden: cost effectiveness analysis. Br Med J1998;316:1417\u201322.","DOI":"10.1136\/bmj.316.7142.1417"},{"key":"key\n\t\t\t\t20170712061443_R9","doi-asserted-by":"crossref","unstructured":"Olsen JA, Richardson J. Production gains from health care: what should be included in cost-effectiveness analysis? Soc Sci Med1999;49:17\u201326.","DOI":"10.1016\/S0277-9536(99)00116-1"},{"key":"key\n\t\t\t\t20170712061443_R10","doi-asserted-by":"crossref","unstructured":"Nord E. Methods for quality adjustment of life years. Soc Sci Med1992;34:559\u201369.","DOI":"10.1016\/0277-9536(92)90211-8"},{"key":"key\n\t\t\t\t20170712061443_R11","doi-asserted-by":"crossref","unstructured":"Nord E. Health status index models for use in resource allocation decisions. A critical review in the light of observed preferences for social choice. Int J Technol Assess Health Care1996;12:31\u201344.","DOI":"10.1017\/S0266462300009363"},{"key":"key\n\t\t\t\t20170712061443_R12","doi-asserted-by":"crossref","unstructured":"Nord E. Cost-Value Analysis in Health Care. New York: Cambridge University Press, 1999.","DOI":"10.1017\/CBO9780511609145"},{"key":"key\n\t\t\t\t20170712061443_R13","unstructured":"McGuire A, Henderson J, Mooney G. The Economics of Health Care. London and New York, Routledge & Kegan Paul, 1988."},{"key":"key\n\t\t\t\t20170712061443_R14","unstructured":"Elvik R. How Much are Avoided Traffic Accidents Worth to Society? Summary Report. [Hvor mye er Unng\u00e5tte Trafikkulykker Verd for Samfunnet? Oppsummeringsrapport.] Oslo: Transport\u00f8konomisk Institutt, 1993."},{"key":"key\n\t\t\t\t20170712061443_R15","doi-asserted-by":"crossref","unstructured":"Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA1996;276:1172\u201377.","DOI":"10.1001\/jama.276.14.1172"},{"key":"key\n\t\t\t\t20170712061443_R16","unstructured":"Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA1996;276:1253\u201358."},{"key":"key\n\t\t\t\t20170712061443_R17","doi-asserted-by":"crossref","unstructured":"Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA1996;276:1339\u201341.","DOI":"10.1001\/jama.276.16.1339"},{"key":"key\n\t\t\t\t20170712061443_R18","doi-asserted-by":"crossref","unstructured":"Touze E, Gessain A, Lyon Caen O, Gout O. Tropical spastic paraparesis\/HTLV-I-associated myelopathy in Europe and in Africa: clinical and epidemiologic aspects. J Acquir Immune Defic Syndr Hum Retrovirol1996;13(Suppl.1):S38\u201345.","DOI":"10.1097\/00042560-199600001-00008"},{"key":"key\n\t\t\t\t20170712061443_R19","unstructured":"Wolfram S. The Mathematica Book, 4th Edn. Champaign, IL: Wolfram Media\/Cambridge University Press, 1999."},{"key":"key\n\t\t\t\t20170712061443_R20","unstructured":"M\u00f8glestue I. Statistical Yearbook. Oslo: Statistics Norway, 1994."},{"key":"key\n\t\t\t\t20170712061443_R21","doi-asserted-by":"crossref","unstructured":"Stigum H, Gr\u00f8nnesby JK, Magnus P, Sundet JM, Bakketeig LS. The potential for spread of HIV in the heterosexual population in Norway: a model study. Stat Med1991;10:1003\u201323.","DOI":"10.1002\/sim.4780100702"},{"key":"key\n\t\t\t\t20170712061443_R22","doi-asserted-by":"crossref","unstructured":"Stigum H, Magnus P, Bakketeig LS. Frequency of sexual partner change in a Norwegian population. Data distribution and covariates. Am J Epidemiol1997;145:636\u201343.","DOI":"10.1093\/oxfordjournals.aje.a009161"},{"key":"key\n\t\t\t\t20170712061443_R23","unstructured":"Ministery of Health and Social Affairs. Diagnosis Related Groups, Hospital Costs 2000. [Prisliste DRG 2000.] http:\/\/odin.dep.no\/shd\/proj\/isf\/2000\/prislistedrg\/2000."},{"key":"key\n\t\t\t\t20170712061443_R24","unstructured":"SINTEF Unimed. Norwegian Patient Registry [Norsk Pasient Register]. http:\/\/www.npr.no\/2000."},{"key":"key\n\t\t\t\t20170712061443_R25","doi-asserted-by":"crossref","unstructured":"Longini IM, Scott Clark W, Haber M, Horsburg R. The stages of HIV infection: waiting times and infection transmission probabilities. Lect Notes Biomath1989;111\u201337.","DOI":"10.1007\/978-3-642-93454-4_5"},{"key":"key\n\t\t\t\t20170712061443_R26","unstructured":"Jacquez JA, Koopman JS, Simon CP, Longini IM, Jr. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immune Defic Syndr1994;7:1169\u201384."},{"key":"key\n\t\t\t\t20170712061443_R27","doi-asserted-by":"crossref","unstructured":"Satten GA, Mastro TD, Longini IM. Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia. Stat Med1994;13:2097\u201306.","DOI":"10.1002\/sim.4780131918"},{"key":"key\n\t\t\t\t20170712061443_R28","doi-asserted-by":"crossref","unstructured":"Kunanusont C, Foy HM, Kreiss JK et al. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet1995;345:1078\u201383.","DOI":"10.1016\/S0140-6736(95)90818-8"},{"key":"key\n\t\t\t\t20170712061443_R29","unstructured":"Bryson Y. Perninatal transmission: associated factors and therapeutic approaches. XI Int Conf on AIDS 1996;Tu.07."},{"key":"key\n\t\t\t\t20170712061443_R30","doi-asserted-by":"crossref","unstructured":"Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model as an example. Int Statist Rev1994;62:229\u201343.","DOI":"10.2307\/1403510"},{"key":"key\n\t\t\t\t20170712061443_R31","doi-asserted-by":"crossref","unstructured":"McKay MD, Beckman RJ, Conover WJ. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics1979;21:239\u201345.","DOI":"10.1080\/00401706.1979.10489755"},{"key":"key\n\t\t\t\t20170712061443_R32","doi-asserted-by":"crossref","unstructured":"Stein M. Large sample properties of simulations using Latin hypercube sampling. Technometrics1987;29:143\u201351.","DOI":"10.1080\/00401706.1987.10488205"},{"key":"key\n\t\t\t\t20170712061443_R33","unstructured":"S-Plus User's Guide. Seattle, WA: Data analysis Products Division, MathSoft, 1997."}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/29\/6\/1076\/18478026\/291076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T09:21:05Z","timestamp":1583313665000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/29.6.1076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2000,12]]},"published-print":{"date-parts":[[2000,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/29.6.1076","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}